$Table 2 from A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies$

Table 2 from A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies

<p>Safety overview.</p>

Saved in:

書目詳細資料
主要作者:	Dejan Juric (15126249) (author)
其他作者:	Daniel Anderson (22644919) (author), Afshin Dowlati (15092092) (author), Jordi Rodon (15047721) (author), Iwona Lugowska (19135437) (author), Sławomir Mańdziuk (22644922) (author), Yuqin Song (15056930) (author), Feng Jung Sherida H. Woei-A-Jin (22644925) (author), Marc André (22644928) (author), Joanna Góra Tybor (22644931) (author), José-Ángel Hernández-Rivas (15050828) (author), Razelle Kurzrock (13559744) (author), Armando López-Guillermo (15028145) (author), David Schröder (22644934) (author), Rafal Stec (22644937) (author), Allison Berger (15134507) (author), Bo Chao (22644940) (author), Aleksander Chudnovsky (22644943) (author), John P. Gibbs (22644946) (author), Tao Long (22644949) (author), Dina Stroopinsky (16732851) (author), Qi Dong (22644952) (author), Anthony J. Olszanski (15031292) (author)
出版:	2025
主題:	Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Combination Immunotherapy Immunology Immune responses to cancer Phase I Clinical Trials
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!